Hong Kong Hospital Authority To Test 3,000 Drugs, Add Suppliers
This article was originally published in PharmAsia News
Executive Summary
Hong Kong's hospital system is establishing a nearly U.S.$4 million safety system to double check the purity of the drugs it buys, and spread its purchases among several distributors. The action is being taken by the Hospital Authority in the wake of death of at least five patient due to a contaminated generic version of Europharm's Purinol (allopurinol). An investigation found generic drugs for public hospitals came from a single distributor. The authority now plans to commission tests on more than 3,000 drugs its hospitals receive to be sure they are not contaminated by bacteria, fungi or yeast. (Click here for more